2013
A prognostic model for predicting overall survival in metastatic castrate-resistant prostate cancer (mCRPC) men treated with second-line chemotherapy.
Halabi S, Lin C, Small E, Armstrong A, Kaplan E, Petrylak D, Sternberg C, Shen L, Oudard S, De Bono J, Sartor A. A prognostic model for predicting overall survival in metastatic castrate-resistant prostate cancer (mCRPC) men treated with second-line chemotherapy. Journal Of Clinical Oncology 2013, 31: 5011-5011. DOI: 10.1200/jco.2013.31.15_suppl.5011.Peer-Reviewed Original ResearchMedian overall survivalSecond-line chemotherapyFirst-line chemotherapyOverall survivalPrognostic modelRisk groupsECOG performance statusPhase III trialsBaseline prognostic factorsLow-risk groupProstate cancer menProstate-specific antigenDocetaxel useLine chemotherapyMCRPC settingMeasurable diseaseIII trialsPerformance statusProgressive diseaseVisceral diseasePrognostic factorsHormonal useClinical trialsProspective validationPrognostic variables
1997
Effectiveness of treatment elements in a residential-work therapy program for veterans with severe substance abuse
Rosenheck R, Seibyl C. Effectiveness of treatment elements in a residential-work therapy program for veterans with severe substance abuse. Psychiatric Services 1997, 48: 928-935. PMID: 9219302, DOI: 10.1176/ps.48.7.928.Peer-Reviewed Original ResearchMeSH KeywordsAdultChi-Square DistributionChronic DiseaseDiagnosis, Dual (Psychiatry)FemaleHumansJob SatisfactionLength of StayLongitudinal StudiesMaleOutcome and Process Assessment, Health CareProgram EvaluationRegression AnalysisSeverity of Illness IndexSheltered WorkshopsSocial AdjustmentSubstance-Related DisordersTreatment OutcomeUnited StatesVeteransConceptsSevere substance abuseSubstance abuseTreatment elementsTherapy programSevere substance use disordersAdmission risk factorsBaseline prognostic factorsLength of staySubstance use disordersPrognostic factorsToxicology screenFunctional statusRisk factorsIntensive treatmentOutcome measuresOutcome dataUse disordersRehabilitative approachVeterans AffairsOutcome domainsSignificant relationshipSubstance useOutcomesVeteransTreatment
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply